Among more than 2,000 patients who completed a TDScreen assessment, 156 received a Tardive Dyskinesia diagnosis and 125 were prescribed treatment, real-world evidence that AI-enabled screening is ...

The first expert consensus recommendations centered on screening, diagnosing and screening tardive dyskinesia (TD) among older adults in long-term care settings were presented at the Society for ...

Expert panel establishes structured approach to tardive dyskinesia screening, diagnosis and treatment in long-term care, including use of VMAT2 inhibitors New post-hoc KINECT‑PRO™ analysis in adults ...

SAN DIEGO, May 5, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc (NBIX). (Nasdaq: NBIX) today announced the release of findings from a new survey conducted by The Harris Poll highlighting the ...

SAN DIEGO, March 26, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the presentation of the first expert consensus recommendations focused on screening, diagnosis and ...

-- Majority of individuals polled reported tardive dyskinesia negatively impacts their day-to-day ability to function, including individuals living with mild or moderate uncontrolled movements1 SAN ...